Australia vs Bhutan: Hepatitis B surface antigen (HBsAg) prevalence
Australia
0.1%
in 2024
Bhutan
0.1%
in 2024
Australia rank
101st
Bhutan rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Australia
- Bhutan
How they compare
Australia currently reports 0.1% against 0.1% in Bhutan, a difference of 0.0%.
Across all 10 years both countries report, Bhutan has been ahead every year.
Australia ranks 101st and Bhutan ranks 101st of 194 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.1% | Bhutan |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Australia or Bhutan?
- Australia, at 0.1% against 0.1% in Bhutan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Australia and Bhutan?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Bhutan?
- 10 years are reported by both, from 2015 to 2024.
- How do Australia and Bhutan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Australia ranks 101st and Bhutan ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.